Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy

Similar Items

• Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score
  od: Akaza, Hideyuki, i dr.
  Izdano: (2013)
• Comparative risk-adjusted mortality outcomes following primary surgery, radiation therapy, or androgen deprivation therapy for localized prostate cancer
  od: Cooperberg, Matthew R., i dr.
  Izdano: (2010)
• Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score
  od: Hideyuki Akaza
  Izdano: (2013-06-01)
• Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
  od: Satoru Ueno, i dr.
  Izdano: (2018-03-01)
• Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
  od: Ueno, Satoru, i dr.
  Izdano: (2018)